Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSLP | Q969D9 | 2/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.42 |
| ▸ | BAD | Q92934 | 2/20 | 0.42 |
| ▸ | NPR1 | P16066 | 1/20 | 0.41 |
| ▸ | NPR3 | P17342 | 1/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.40 |
| ▸ | BECN1 | Q14457 | 4/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.39 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.39 |
| ▸ | MC4R | P32245 | 1/20 | 0.39 |
| ▸ | MC3R | P41968 | 1/20 | 0.39 |
| ▸ | MC1R | Q01726 | 1/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.39 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.39 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.39 |
| ▸ | CTSG | P08311 | 1/20 | 0.38 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13748393 | 0.86 | ALB (0.45) | TSLPALBMC4RMC3RMC1R | |
| SCHEMBL7008808 | 0.85 | ALB (0.45) | TSLPALBMC4RMC3RMC1R | |
| SCHEMBL16298642 | 0.83 | ALB (0.47) | TSLPALBBCL2L1BADNPR1 | |
| SCHEMBL13755375 | 0.82 | TSLP (0.41) | TSLPALBCTSGIL23R | |
| SCHEMBL13486079 | 0.79 | NPR1 (0.51) | TSLPALBBCL2L1BADNPR1 | |
| SCHEMBL16325464 | 0.78 | ALB (0.46) | TSLPALBNPR1NPR3TNFSF11 | |
| SCHEMBL10327411 | 0.78 | NPR1 (0.50) | TSLPALBBCL2L1BADNPR1 | |
| SCHEMBL9909406 | 0.76 | ALB (0.47) | TSLPALBBCL2L1BADNPR1 | |
| SCHEMBL14029125 | 0.76 | CTSG (0.50) | TSLPALBBCL2L1BADNPR1 | |
| SCHEMBL13590621 | 0.75 | ALB (0.48) | TSLPALBBCL2L1BADNPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8182790-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2012-05-22 | — | — | US | disclosed |
| US-20090208412-A1 | Contrast Agents | GE HEALTHCARE AS (NO) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208412-A1 | Contrast Agents | COL2A1, COL1A1, COL14A1 | TSLP 3139/4885ALB 210/4885BCL2L1 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.